“Real-World Safety Profile of Generic Palbociclib in Hormone Receptor–Positive, HER2-Negative Metastatic Breast Cancer: A Prospective Observational Study in Iraq””. Journal of Cancer Research Updates 15, no. 1 (June 9, 2026): 150–155. Accessed June 10, 2026. https://www.neoplasiaresearch.com/index.php/jcru/article/view/960.